The Closed System Drug Transfer Device Market is witnessing significant growth due to increasing awareness about healthcare-worker safety and the risks associated with handling hazardous medications. Closed system drug transfer devices provide a controlled barrier during drug preparation and administration, helping reduce the possibility of contamination and occupational exposure.

Market Research Future estimates that the market will expand from USD 1.52 billion in 2025 to USD 5.42 billion by 2035, reflecting a CAGR of 13.6%.

One of the major market trends is the growing adoption of needleless systems. These systems help eliminate sharps-related risks while supporting safer medication preparation. Membrane-to-membrane systems are also gaining attention, particularly in high-volume compounding environments.

Technological advancements are creating additional opportunities. Manufacturers are developing devices with improved containment, easier connections, enhanced ergonomics, and compatibility with automated pharmacy systems. Digital technologies may also support monitoring and documentation of drug-transfer activities.

Hospitals and clinics represent the major end-user segment because of the high volume of hazardous drug preparation and chemotherapy administration. Specialty oncology centers are also expected to contribute to future demand.

Regionally, North America remains a major market, while Asia-Pacific is projected to grow rapidly. Increasing healthcare expenditure, cancer treatment infrastructure, regulatory developments, and awareness of occupational safety will continue to support market development.